Frontier Biotechnologies Inc. Class ASSE: 688221

Announcement on Convening the Q3 2025 Performance Briefing

Oct 31, 2025 · Issued by Frontier Biotechnologies Inc. Class A via Shanghai Stock Exchange

Announcement on Convening the Q3 2025 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment